is mounjaro glp 1 agonist 💉 Ozempic & Mounjaro: What You Need to Know You might know them as

10.2337/db11-1506 [DOI] [PMC free article] [PubMed] [Google Scholar] 92.Baturcam E, Abubaker J, Tiss A, Abu-Farha M, Khadir A, Al-Ghimlas F, et al

doi: 10.1210/endo-119-4-1467

Dulaglutide is a long-acting GLP-1RA used for T2DM with demonstrated cardiovascular benefits.[10] Liraglutide, another long-acting GLP-1RA, is used for T2DM and obesity management and is under investigation for Alzheimers disease and metabolic-associated hepatic steatosis.[4] Lixisenatide, a short-acting GLP-1RA, shows comparable efficacy to exenatide and liraglutide for T2DM management, and is now combined with insulin glargine.[23] Semaglutide, available in injectable and oral forms, has demonstrated benefits in promoting weight loss, reducing risk of cardiovascular events, and slowing progression of diabetic CKD.[24] Finally, tirzepatide is a dual agonist for receptors of GLP and glucose-dependent insulinotropic polypeptide (GIP), a hormone released from the intestines in response to macronutrients.[25] These two mechanisms of action have synergistic glucose-lowering and weight loss effects with lower side effect rates than other GLP-1RAs.[25] Tirzepatide has also been shown to result in blood pressure reduction, obstructive sleep apnea control, and improved cholesterol in T2DM patients.[5] Table

#PharmaIndustry #Healthcare #DrugSafety #Pharmacovigilance #Pregabalin #RegulatoryAffairs #Pharmaceuticals #HealthcareManagement #PatientSafetyA To view or add a comment, sign in SEC Recommendation Update | Pharminho Upcoming Drugs SEC has recommended Marketing Authorisation for Ademetionine-1,4-Butanedisulfonate Lyophilized Powder for Solution for Injection to M/s La Renon Healthcare Pvt.Ltd